Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Anixa Biosciences Inc | ANIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.10 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.10 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2.75 - 5.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.10 | USD |
Anixa Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 98.89M | 31.90M | - | 210k | -9.81M | -0.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Anixa Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANIX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.23 | 3.2499 | 3.03 | 3.13 | 71,685 | -0.13 | -4.02% |
| 1 Month | 3.68 | 3.70 | 3.03 | 3.22 | 80,577 | -0.58 | -15.76% |
| 3 Months | 4.45 | 4.70 | 3.01 | 3.71 | 116,766 | -1.35 | -30.34% |
| 6 Months | 3.26 | 5.13 | 2.75 | 3.91 | 150,248 | -0.16 | -4.91% |
| 1 Year | 4.70 | 5.13 | 2.75 | 3.79 | 112,876 | -1.60 | -34.04% |
| 3 Years | 3.83 | 6.45 | 2.30 | 4.09 | 121,307 | -0.73 | -19.06% |
| 5 Years | 4.23 | 8.09 | 1.33 | 3.74 | 182,889 | -1.13 | -26.71% |
Anixa Biosciences Description
| Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumours which is based on the body's immune response to the presence of a malignancy. The company is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs that genetically engineer patient's own immune cells to fight cancer. |
